The Carboxyl-terminal Region of the Geranylgeranyl Diphosphate Synthase is Indispensable for the Stabilization of the Region Involved in Substrate Binding and Catalysis
Abstract:Rat geranylgeranyl diphosphate synthase (GGPS) and its deletion mutants from the carboxyl terminus were analysed using Escherichia coli harbouring pACYC-crtIB, which contains crtI and crtB encoding the carotenoid biosynthetic enzymes. Mutants (delta-4, -8, -12 and -16) produced lycopene-derived red colour, but mutants (delta-17, -18, -19, -20, -23, -57 and -70) did not. The histidine-tagged mutants (delta-4, -8, -12 and -16) were overexpressed in E. coli BL21 (DE3) and purified in a stable form by nickel affin… Show more
“…The pathogenic variants fell within a specific 5 amino acid region toward the C terminus around the start of helix 11, with as of yet unclear function (Fig 3A). In animals, geranylgeranyl diphosphate synthase is formed as a hexamer and in certain circumstances as an octamer, whereas in plants it is a dimer 17 . In silico modeling of GGPPS hexamer shows that this domain, in which all but one of the pathogenic variants (P15S) were clustered, is located toward the outside of the hexamer and not in the barrel where the catalytic core of the enzyme is located (Fig 4A).…”
Section: Resultsmentioning
confidence: 99%
“…In animals, geranylgeranyl diphosphate synthase is formed as a hexamer and in certain circumstances as an octamer, whereas in plants it is a dimer. 17 In silico modeling of GGPPS hexamer shows that this domain, in which all but one of the pathogenic variants (P15S) were clustered, is located toward the outside of the hexamer and not in the barrel where the catalytic core of the enzyme is located (Fig 4A). The first α-helix containing the P15S mutation is conserved and involved in the formation of the trimer from the dimers (see Fig 3A).…”
Section: Gene Identification and Mutationsmentioning
Objective
A hitherto undescribed phenotype of early onset muscular dystrophy associated with sensorineural hearing loss and primary ovarian insufficiency was initially identified in 2 siblings and in subsequent patients with a similar constellation of findings. The goal of this study was to understand the genetic and molecular etiology of this condition.
Methods
We applied whole exome sequencing (WES) superimposed on shared haplotype regions to identify the initial biallelic variants in GGPS1 followed by GGPS1 Sanger sequencing or WES in 5 additional families with the same phenotype. Molecular modeling, biochemical analysis, laser membrane injury assay, and the generation of a Y259C knock‐in mouse were done.
Results
A total of 11 patients in 6 families carrying 5 different biallelic pathogenic variants in specific domains of GGPS1 were identified. GGPS1 encodes geranylgeranyl diphosphate synthase in the mevalonate/isoprenoid pathway, which catalyzes the synthesis of geranylgeranyl pyrophosphate, the lipid precursor of geranylgeranylated proteins including small guanosine triphosphatases. In addition to proximal weakness, all but one patient presented with congenital sensorineural hearing loss, and all postpubertal females had primary ovarian insufficiency. Muscle histology was dystrophic, with ultrastructural evidence of autophagic material and large mitochondria in the most severe cases. There was delayed membrane healing after laser injury in patient‐derived myogenic cells, and a knock‐in mouse of one of the mutations (Y259C) resulted in prenatal lethality.
Interpretation
The identification of specific GGPS1 mutations defines the cause of a unique form of muscular dystrophy with hearing loss and ovarian insufficiency and points to a novel pathway for this clinical constellation. ANN NEUROL 2020;88:332–347.
“…The pathogenic variants fell within a specific 5 amino acid region toward the C terminus around the start of helix 11, with as of yet unclear function (Fig 3A). In animals, geranylgeranyl diphosphate synthase is formed as a hexamer and in certain circumstances as an octamer, whereas in plants it is a dimer 17 . In silico modeling of GGPPS hexamer shows that this domain, in which all but one of the pathogenic variants (P15S) were clustered, is located toward the outside of the hexamer and not in the barrel where the catalytic core of the enzyme is located (Fig 4A).…”
Section: Resultsmentioning
confidence: 99%
“…In animals, geranylgeranyl diphosphate synthase is formed as a hexamer and in certain circumstances as an octamer, whereas in plants it is a dimer. 17 In silico modeling of GGPPS hexamer shows that this domain, in which all but one of the pathogenic variants (P15S) were clustered, is located toward the outside of the hexamer and not in the barrel where the catalytic core of the enzyme is located (Fig 4A). The first α-helix containing the P15S mutation is conserved and involved in the formation of the trimer from the dimers (see Fig 3A).…”
Section: Gene Identification and Mutationsmentioning
Objective
A hitherto undescribed phenotype of early onset muscular dystrophy associated with sensorineural hearing loss and primary ovarian insufficiency was initially identified in 2 siblings and in subsequent patients with a similar constellation of findings. The goal of this study was to understand the genetic and molecular etiology of this condition.
Methods
We applied whole exome sequencing (WES) superimposed on shared haplotype regions to identify the initial biallelic variants in GGPS1 followed by GGPS1 Sanger sequencing or WES in 5 additional families with the same phenotype. Molecular modeling, biochemical analysis, laser membrane injury assay, and the generation of a Y259C knock‐in mouse were done.
Results
A total of 11 patients in 6 families carrying 5 different biallelic pathogenic variants in specific domains of GGPS1 were identified. GGPS1 encodes geranylgeranyl diphosphate synthase in the mevalonate/isoprenoid pathway, which catalyzes the synthesis of geranylgeranyl pyrophosphate, the lipid precursor of geranylgeranylated proteins including small guanosine triphosphatases. In addition to proximal weakness, all but one patient presented with congenital sensorineural hearing loss, and all postpubertal females had primary ovarian insufficiency. Muscle histology was dystrophic, with ultrastructural evidence of autophagic material and large mitochondria in the most severe cases. There was delayed membrane healing after laser injury in patient‐derived myogenic cells, and a knock‐in mouse of one of the mutations (Y259C) resulted in prenatal lethality.
Interpretation
The identification of specific GGPS1 mutations defines the cause of a unique form of muscular dystrophy with hearing loss and ovarian insufficiency and points to a novel pathway for this clinical constellation. ANN NEUROL 2020;88:332–347.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.